New Technology Detects Breast Cancer Relapses up to Five Years in Advance

Cancer DNA is detectable in blood years before diagnosis

Tiny, newly formed tumors shed small fragments of DNA that are swept into the bloodstream. Future cancer screening tests could detect them early.

New technology detects breast cancer relapses up to five years in advance

Altum Sequencing, a start-up supported by the C3N-IA Science Park at Universidad Carlos III de Madrid (UC3M) and specialized in oncology, has developed a tool to monitor treatment response in patients with solid tumors from a simple blood sample. This advance could represent a turning point in post-treatment follow-up.

Altum Sequencing develops tool to monitor solid tumour treatment response

Altum Sequencing has developed a tool that uses a simple blood sample for monitoring treatment response in individuals with solid tumours.The post Altum Sequencing develops tool to monitor solid tumour treatment response appeared first on Medical Device Network.